Seres Therapeutics MCRB
NASDAQ MCRB
$2.13 -0.17 (-7.39%)
At close: Oct 22, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Cash from Financing Activities (2014 - 2026)

Updated

Seres Therapeutics' Cash from Financing Activities was $1.72 million in Q2 2026, up 300.7% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Cash from Financing Activities (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Seres Therapeutics' Cash from Financing Activities was $14.86 million through Jun 30, 2026; for FY2025, it came in at $13.9 million.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -46.0% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was -$90.37 million in FY2024, $71.71 million in FY2023 (-44.7%), $129.6 million in FY2022 and $1.18 million in FY2021 (-99.6%).
  • Quarterly Cash from Financing Activities has moved between -$110.87 million (Q3 2024) and $98.03 million (Q3 2022) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last four quarters, with growth averaging 99.6%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2025 (growth of 628.7%); the worst was Q3 2021 (a decline of 99.8%).
  • Per Business Quant data, MCRB's Cash from Financing Activities in the three quarters before Q2 2026 was $428,000 (Q1 2026), $12.66 million (Q4 2025) and $61,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -8.53 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -5.05 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -3.89 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 2.34 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -3.66 Bn
10 Seres Therapeutics 20.93 Mn -117.90 Mn - 1.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.72 Mn
Mar 31, 2026 428,000.00
Dec 31, 2025 12.66 Mn
Sep 30, 2025 61,000.00
Mar 31, 2025 1.18 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 -110.87 Mn
Mar 31, 2024 18.76 Mn
Dec 31, 2023 6.43 Mn
Sep 30, 2023 1.44 Mn
Jun 30, 2023 58.18 Mn
Mar 31, 2023 5.66 Mn
Dec 31, 2022 4.60 Mn
Sep 30, 2022 98.03 Mn
Jun 30, 2022 130,000.00
Mar 31, 2022 26.85 Mn
Dec 31, 2021 -780,000.00
Sep 30, 2021 609,000.00
Jun 30, 2021 585,000.00
Mar 31, 2021 764,000.00
API Access

Seres Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MCRB&period=max&api_key=YOUR_API_KEY